TDMS Study 96002-02 Pathology Tables
NTP Experiment-Test: 96002-02 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02
Study Type: 14DAY REPEATED DIAZOAMINOBENZENE (DAAB) Date: 09/27/00
Route: SKIN APPLICATION Time: 08:19:20
FINAL#1; 17 DAY REPEATED DOSE
Facility: BIORELIANCE
Chemical CAS #: 136-35-6
Lock Date: 01/21/99
Cage Range: All
Reasons For Removal: All
Removal Date Range: All
Treatment Groups: Include All
a Number of animals examined microscopically at site and number of animals with lesion
Page 1
NTP Experiment-Test: 96002-02 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02
Study Type: 14DAY REPEATED DIAZOAMINOBENZENE (DAAB) Date: 09/27/00
Route: SKIN APPLICATION Time: 08:19:20
____________________________________________________________________________________________________________________________________
B6C3F1 MICE FEMALE 0 MG/KG 12.5 25 MG/KG 50 MG/KG 100 200
MG/KG MG/KG MG/KG
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY
Animals Initially in Study 5 5 5 5 5 5
Early Deaths
Moribund Sacrifice 2
Natural Death 1
Survivors
Terminal Sacrifice 5 5 5 5 5 2
Animals Examined Microscopically 5 5 5 5 5 5
____________________________________________________________________________________________________________________________________
ALIMENTARY SYSTEM
None
____________________________________________________________________________________________________________________________________
CARDIOVASCULAR SYSTEM
None
____________________________________________________________________________________________________________________________________
ENDOCRINE SYSTEM
None
____________________________________________________________________________________________________________________________________
GENERAL BODY SYSTEM
None
____________________________________________________________________________________________________________________________________
GENITAL SYSTEM
None
____________________________________________________________________________________________________________________________________
HEMATOPOIETIC SYSTEM
None
____________________________________________________________________________________________________________________________________
Page 2
NTP Experiment-Test: 96002-02 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02
Study Type: 14DAY REPEATED DIAZOAMINOBENZENE (DAAB) Date: 09/27/00
Route: SKIN APPLICATION Time: 08:19:20
____________________________________________________________________________________________________________________________________
B6C3F1 MICE FEMALE 0 MG/KG 12.5 25 MG/KG 50 MG/KG 100 200
MG/KG MG/KG MG/KG
____________________________________________________________________________________________________________________________________
INTEGUMENTARY SYSTEM
None
____________________________________________________________________________________________________________________________________
MUSCULOSKELETAL SYSTEM
None
____________________________________________________________________________________________________________________________________
NERVOUS SYSTEM
None
____________________________________________________________________________________________________________________________________
RESPIRATORY SYSTEM
None
____________________________________________________________________________________________________________________________________
SPECIAL SENSES SYSTEM
None
____________________________________________________________________________________________________________________________________
URINARY SYSTEM
None
Page 3
NTP Experiment-Test: 96002-02 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02
Study Type: 14DAY REPEATED DIAZOAMINOBENZENE (DAAB) Date: 09/27/00
Route: SKIN APPLICATION Time: 08:19:20
____________________________________________________________________________________________________________________________________
B6C3F1 MICE MALE 0 MG/KG 12.5 25 MG/KG 50 MG/KG 100 200
MG/KG MG/KG MG/KG
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY
Animals Initially in Study 5 5 5 5 5 5
Early Deaths
Moribund Sacrifice 4 5 5
Survivors
Terminal Sacrifice 5 5 5 1
Animals Examined Microscopically 5 5 5 5 5 5
____________________________________________________________________________________________________________________________________
ALIMENTARY SYSTEM
None
____________________________________________________________________________________________________________________________________
CARDIOVASCULAR SYSTEM
None
____________________________________________________________________________________________________________________________________
ENDOCRINE SYSTEM
None
____________________________________________________________________________________________________________________________________
GENERAL BODY SYSTEM
None
____________________________________________________________________________________________________________________________________
GENITAL SYSTEM
None
____________________________________________________________________________________________________________________________________
HEMATOPOIETIC SYSTEM
None
____________________________________________________________________________________________________________________________________
Page 4
NTP Experiment-Test: 96002-02 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02
Study Type: 14DAY REPEATED DIAZOAMINOBENZENE (DAAB) Date: 09/27/00
Route: SKIN APPLICATION Time: 08:19:20
____________________________________________________________________________________________________________________________________
B6C3F1 MICE MALE 0 MG/KG 12.5 25 MG/KG 50 MG/KG 100 200
MG/KG MG/KG MG/KG
____________________________________________________________________________________________________________________________________
INTEGUMENTARY SYSTEM
None
____________________________________________________________________________________________________________________________________
MUSCULOSKELETAL SYSTEM
None
____________________________________________________________________________________________________________________________________
NERVOUS SYSTEM
None
____________________________________________________________________________________________________________________________________
RESPIRATORY SYSTEM
None
____________________________________________________________________________________________________________________________________
SPECIAL SENSES SYSTEM
None
____________________________________________________________________________________________________________________________________
URINARY SYSTEM
None
Page 5
------------------------------------------------------------
---------- END OF REPORT ----------
------------------------------------------------------------